Litigation Details for Biogen International GmbH v. Glenmark Pharmaceuticals Limited (D. Del. 2017)
✉ Email this page to a colleague
Biogen International GmbH v. Glenmark Pharmaceuticals Limited (D. Del. 2017)
Docket | ⤷ Try a Trial | Date Filed | 2017-06-28 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Patents | 7,320,999; 8,399,514 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Biogen International GmbH v. Glenmark Pharmaceuticals Limited
Details for Biogen International GmbH v. Glenmark Pharmaceuticals Limited (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-06-28 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,320,999; 6,509,376; 8,399,514… 28 June 2017 1:17-cv-00852 835 Patent - Abbreviated New Drug Application(ANDA) | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |